Cardinal, NCT03347396 / 2017-003538-10: A Study to Assess the Efficacy and Safety of BIVV009 (Sutimlimab) in Participants With Primary Cold Agglutinin Disease Who Have a Recent History of Blood Transfusion ( Study) |
|
|
| Completed | 3 | 24 | Europe, Canada, Japan, US, RoW | BIVV009, Sutimlimab | Bioverativ, a Sanofi company | Agglutinin Disease, Cold | 10/21 | 10/21 | | |
Cadenza, NCT03347422 / 2017-003539-12: A Study to Assess the Efficacy and Safety of BIVV009 (Sutimlimab) in Participants With Primary Cold Agglutinin Disease Without A Recent History of Blood Transfusion |
|
|
| Completed | 3 | 42 | Europe, Canada, Japan, US, RoW | sutimlimab (BIVV009), placebo | Bioverativ, a Sanofi company | Cold Agglutinin Disease | 12/21 | 12/21 | | |
